D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 17,637 275 World Ranking 12968 National Ranking 433

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

His primary areas of study are Internal medicine, Endocrinology, Thyroid, Thyroid cancer and Thyroid carcinoma. Many of his studies involve connections with topics such as Pathology and Internal medicine. Sebastiano Filetti has included themes like Carcinoma and Lymph node in his Endocrinology study.

His biological study spans a wide range of topics, including Hormone and Stimulation. In his work, Polymerase chain reaction and Medical diagnosis is strongly intertwined with Fine-needle aspiration, which is a subfield of Thyroid cancer. Sebastiano Filetti interconnects Calcitonin, Cancer, Cancer research, Apical membrane and Pendred syndrome in the investigation of issues within Thyroid carcinoma.

His most cited work include:

  • Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial (524 citations)
  • BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism (286 citations)
  • Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. (284 citations)

What are the main themes of his work throughout his whole career to date?

Sebastiano Filetti focuses on Internal medicine, Endocrinology, Thyroid, Thyroid cancer and Cancer research. The Internal medicine study combines topics in areas such as Gastroenterology and Oncology. His work on Stimulation and Thyrotropin receptor as part of general Endocrinology research is frequently linked to Sodium-iodide symporter and Context, bridging the gap between disciplines.

His Thyroid study combines topics in areas such as Carcinoma and Pathology. His Thyroid cancer study integrates concerns from other disciplines, such as Hormone and Regulation of gene expression. His Cancer research research focuses on subjects like Cell culture, which are linked to Molecular biology.

He most often published in these fields:

  • Internal medicine (55.65%)
  • Endocrinology (46.09%)
  • Thyroid (42.90%)

What were the highlights of his more recent work (between 2016-2021)?

  • Thyroid (42.90%)
  • Thyroid cancer (25.51%)
  • Internal medicine (55.65%)

In recent papers he was focusing on the following fields of study:

Sebastiano Filetti spends much of his time researching Thyroid, Thyroid cancer, Internal medicine, Radiology and Thyroid nodules. His Thyroid research is multidisciplinary, relying on both Cancer, Nodule, Pathology, Risk stratification and Artificial intelligence. The various areas that Sebastiano Filetti examines in his Thyroid cancer study include Cancer research, microRNA, Cohort and Thyroidectomy.

The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Oncology. His Endocrinology research incorporates elements of Soft tissue, Mutation testing, Propensity score matching and Recurrence risk. His Thyroid nodules research includes elements of Preoperative care and Ultrasonography.

Between 2016 and 2021, his most popular works were:

  • The Diagnosis and Management of Thyroid Nodules: A Review (135 citations)
  • Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (90 citations)
  • Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the “Right” TIRADS (82 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Sebastiano Filetti mainly focuses on Thyroid cancer, Thyroid, Internal medicine, Thyroidectomy and Thyroid nodules. His Thyroid cancer research is multidisciplinary, incorporating perspectives in Therapeutic approach, Risk stratification, Incidence and MEDLINE. He is studying Thyroid carcinoma, which is a component of Thyroid.

The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. His work deals with themes such as Cancer staging, Cancer recurrence, Cancer surgery, General surgery and TNM staging system, which intersect with Thyroidectomy. His studies in Thyroid nodules integrate themes in fields like Ultrasonography and Radiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Richard E Pratley;Michael Nauck;Timothy Bailey;Eduard Montanya.
The Lancet (2010)

691 Citations

Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients*

Bernadette Biondi;Emiliano Antonio Palmieri;Serafino Fazio;Carmela Cosco.
The Journal of Clinical Endocrinology and Metabolism (2000)

498 Citations

Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.

Vladimir Lazar;Jean Michel Bidart;Bernard Caillou;Cedric Mahé.
The Journal of Clinical Endocrinology and Metabolism (1999)

425 Citations

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

C. Durante;E. Puxeddu;E. Ferretti;R. Morisi.
The Journal of Clinical Endocrinology and Metabolism (2007)

390 Citations

Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules

Giuseppe Costante;Domenico Meringolo;Cosimo Durante;Davide Bianchi.
The Journal of Clinical Endocrinology and Metabolism (2007)

384 Citations

Increased aggressiveness of thyroid cancer in patients with Graves' disease

Antonino Belfiore;Maria Rita Garofalo;Dario Giuffrida;Filippo Runello.
The Journal of Clinical Endocrinology and Metabolism (1990)

351 Citations

Adenovirus-mediated Transfer of the Thyroid Sodium/Iodide Symporter Gene into Tumors for a Targeted Radiotherapy

Anne Boland;Marcel Ricard;Paule Opolon;Jean Michel Bidart.
Cancer Research (2000)

348 Citations

Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.

Sebastiano Filetti;Jean Michel Bidart;Franco Arturi;Bernard Caillou.
European Journal of Endocrinology (1999)

343 Citations

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel‐group, open‐label trial

R. Pratley;M. Nauck;T. Bailey;E. Montanya.
International Journal of Clinical Practice (2011)

334 Citations

Subclinical hyperthyroidism: clinical features and treatment options

Bernadette Biondi;Emiliano Antonio Palmieri;Michele Klain;Martin Schlumberger.
European Journal of Endocrinology (2005)

309 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sebastiano Filetti

Martin Schlumberger

Martin Schlumberger

Institut Gustave Roussy

Publications: 77

Furio Pacini

Furio Pacini

University of Siena

Publications: 57

Rossella Elisei

Rossella Elisei

University of Pisa

Publications: 50

Jacques Emile Dumont

Jacques Emile Dumont

Université Libre de Bruxelles

Publications: 48

Sandra M. McLachlan

Sandra M. McLachlan

Cedars-Sinai Medical Center

Publications: 45

Aldo Pinchera

Aldo Pinchera

University of Pisa

Publications: 44

Sophie Leboulleux

Sophie Leboulleux

Institut Gustave Roussy

Publications: 43

R. Michael Tuttle

R. Michael Tuttle

Memorial Sloan Kettering Cancer Center

Publications: 40

Basil Rapoport

Basil Rapoport

University of California, San Francisco

Publications: 38

Paolo Vitti

Paolo Vitti

University of Pisa

Publications: 36

Kenneth D. Burman

Kenneth D. Burman

MedStar Washington Hospital Center

Publications: 36

Gilbert Vassart

Gilbert Vassart

Université Libre de Bruxelles

Publications: 32

Ernest L. Mazzaferri

Ernest L. Mazzaferri

The Ohio State University

Publications: 31

Julie A. Sosa

Julie A. Sosa

University of California, San Francisco

Publications: 31

Karel Pacak

Karel Pacak

National Institutes of Health

Publications: 30

Leonard Wartofsky

Leonard Wartofsky

MedStar Washington Hospital Center

Publications: 29

Trending Scientists

Z. Morley Mao

Z. Morley Mao

University of Michigan–Ann Arbor

John Harer

John Harer

Duke University

benjamin n eldridge

benjamin n eldridge

Nutcracker Therapeutics

Ahmed S. Elwakil

Ahmed S. Elwakil

University of Sharjah

Motoichi Ohtsu

Motoichi Ohtsu

University of Tokyo

Andrew J. Lovinger

Andrew J. Lovinger

Alcatel Lucent (Germany)

Larry C. Sieker

Larry C. Sieker

University of Washington

Renée K. Margolis

Renée K. Margolis

State University of New York

Binhai Zheng

Binhai Zheng

University of California, San Diego

Alexandros G. Georgakilas

Alexandros G. Georgakilas

National Technical University of Athens

Shiranee Sriskandan

Shiranee Sriskandan

Imperial College London

Haflidi Haflidason

Haflidi Haflidason

Bjerknes Centre for Climate Research

Rendeng Shi

Rendeng Shi

Chinese Academy of Sciences

Kalyanam Shivkumar

Kalyanam Shivkumar

University of California, Los Angeles

Lawrence H. Einhorn

Lawrence H. Einhorn

Indiana University

Elliott S. Fisher

Elliott S. Fisher

Dartmouth Institute for Health Policy and Clinical Practice

Something went wrong. Please try again later.